Viewing Study NCT00139087



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00139087
Status: COMPLETED
Last Update Posted: 2005-08-31
First Post: 2005-08-29

Brief Title: Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy TOT Trial
Sponsor: Centers for Disease Control and Prevention
Organization: Centers for Disease Control and Prevention

Study Overview

Official Title: Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy TOT Trial
Status: COMPLETED
Status Verified Date: 2005-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Telephone Outreach for Therapy Trial was designed to test an intervention to assist new mothers or caregivers of HIV-exposed children with administering medication for the first 6 weeks of life to prevent mother-to-child HIV infection in the infants To be eligible mothers of infants were identified as HIV-infected in the Mother-Infant Rapid Intervention at Delivery Study Mothers or caregivers of infants were randomized into two groups the intervention group received a cellular phone and scheduled twice daily calls to assure infant medications were given and the other group received the current standard of care Enrollment into the study was completed and analysis of the study data is underway
Detailed Description: The Telephone Outreach for Therapy Trial was designed to test an intervention to assist new mothers or caregivers of HIV-exposed children with administering medication for the first 6 weeks of life to prevent mother-to-child HIV infection in the infants To be eligible mothers of infants were identified as HIV-infected in the Mother-Infant Rapid Intervention at Delivery Study Mothers or caregivers of infants were randomized into two groups the intervention group received a cellular phone and scheduled twice daily calls to assure infant medications were given and the other group received the current standard of care Enrollment into the study was completed and analysis of the study data is underway

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None